1. Reynen K. Cardiac myxomas. N Engl J Med. 1995. 333:1610–1617.
Article
2. Pinede L, Duhaut P, Loire R. Clinical presentation of left atrial cardiac myxoma: a series of 112 consecutive cases. Medicine. 2001. 80:159–172.
Article
3. Keeling IM, Oberwalder P, Anelli-Monti M, Schuchlenz H, Demel U, Tilz GP, Rehak P, Rigler B. Cardiac myxoma: 24 years of experience in 49 patients. Eur J Cardiothorac Surg. 2002. 22:971–977.
4. M. Nadeem Attar, Roger K. Moore, Sarfraz Khan. Left atrial myxoma presenting with ventricular fibrillation. J Cardiovasc Med (Hagerstown). 2008. 9:282–284.
Article
5. Marcus GM, Smith LM, Glidden DV, Wilson E, McCabe JM, Whiteman D, Tseng ZH, Badhwar N, Lee BK, Lee RJ, Scheinman MM, Olgin JE. Markers of inflammation before and after curative ablation of atrial flutter. Heart Rhythm. 2008. 5:215–221.
Article
6. Mendoza CE, Rosado MF, Bemal L. The role of interleukin-6 in cases of cardiac myxoma: Clinical features, immunologic abnormalities, and a possible role in recurrence. Tex Heart Inst J. 2001. 28:3–7.
7. Koo SH, Cha TJ, Choi YJ, Yoo CH, Kim HS, Heo JH, Nattel S, Lee JW. Evidence for a role of inflammation in atrial fibrillation associated with heart failure and the protective effects of angiotensin receptor blockade. Heart Rhythm. 2008. 5:S263.